Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human FABP6 Antibody, R&D Systems™

Goat Polyclonal Antibody
Supplier: R&D Systems AF3880
This item is not returnable.
View return policy
Description
Produced in goats immunized with purified, E. coli-derived, recombinant human FABP6 (rhFABP6; aa 2 - 128; Accession # P51161). Human FABP6 specific IgG was purified by human FABP6 affinity chromatography.
FABP6 Polyclonal specifically detects FABP6 in Human samples. It is validated for Western Blot, Immunocytochemistry.Specifications
FABP6 | |
Polyclonal | |
Unconjugated | |
P51161 | |
FABP6 | |
E. coli-derived recombinant human FABP6 Ala2-Ala128 Accession # P51161 | |
100 μg | |
Primary | |
Detects human FABP6 in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 5% cross-reactivity with recombinant human (rh) FABP1, rhFABP2, rhFABP3, rhFABP4, rhFABP5, rhFABP7, and recombinant mouse FABP9 is observed. | |
Human | |
IgG |
Western Blot, Immunocytochemistry | |
LYOPH | |
Western Blot 0.1 ug/mL, Immunocytochemistry 5-15 ug/mL | |
fatty acid binding protein 6, ileal, Fatty acid-binding protein 6, gastrotropin, I-15P, I-15PIntestinal 15 kDa protein, IBABP, I-BABPIntestinal bile acid-binding protein, I-BALB, I-BAP, ILBP, ILBP3, ILBPGT, ileal bile acid binding protein, ILLBP, ILLBPIleal lipid-binding protein, illeal lipid-binding protein | |
Goat | |
Affinity Purified | |
RUO | |
2172 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction